GEN is established in 1998.
Our company, which provides global solutions for rare diseases and unmet health needs, began operations in 1998.
1998
GEN & Biogen
A collaboration agreement has been signed between our company and Biogen, one of the largest companies in Multiple Sclerosis.
2007
New Headquarters
Our headquarters in Ankara has been relocated to a new central office building.
2010
Genject Syringe Manufacturing
Genject, one of our affiliated companies, has commenced operations in syringe manufacturing.
2011
GEN Kazakhstan Office
In line with our goal to become a global player, we have inaugurated our office in Kazakhstan, marking one of our initial steps in this direction.
2014
Construction of Our Manufacturing Facility Has Begun.
Following the groundbreaking ceremony, construction of our manufacturing facility has commenced.
2015
AİFD Membership
We have become a member of the Association of Research-Based Pharmaceutical Companies, contributing to the accessibility of new and innovative medicines for the Turkish population and supporting the development of practical solutions for health issues in our country.
2016
GEN Azerbaijan Office
The opening of our Azerbaijan office has been completed.
2017
GEN Manufacturing Facility
GEN manufacturing facility, with its two distinct production areas, commenced operations in 2017.
2019
GMP Certifications for Russia, Azerbaijan, and Kazakhstan
GMP certifications for Russia, Azerbaijan, and Kazakhstan have been obtained, and production for global markets has commenced.
2019
Elixir Has Become a Part of GEN.
Elixir, a pharmaceutical research and development company founded in 2014, is known for its high-tech laboratories, scientific infrastructure, and innovative thinking. In 2019, it joined GEN and became part of GEN's R&D activities through its developed products.
2019
R&D Center Approval
GEN's R&D centre, with its 1,200 m² laboratory space, competent research infrastructure, and well-equipped facilities, received approval as an R&D centre from the Ministry of Industry and Technology of the Republic of Türkiye in 2019.
2020
Offices in Russia, Uzbekistan, and Germany
The openings of our offices in Russia and Uzbekistan and our representative office in Germany have been completed.
2021
GEN & Turquality
GEN has been included in the Turquality program, a global branding initiative.
2021
GEN Has Been Listed on The Stock Exchange!
The opening bell rang for GEN at Borsa İstanbul, marking the company's initial public offering.
2021
FDA Approval for Philippines
FDA approval for the Philippines has been obtained.
2021
GEN Manufacturing Facility EU GMP Approval
EU GMP approval has been obtained for some of the products manufactured at our facility.
2022
GEN Georgia Office
The opening of our Georgia office has been completed.
2023
Our First OTC Product
Sales, marketing, and promotional activities have commenced for B-Sync ON, our first OTC product featuring patented technology for delayed caffeine release.
2023
GEN & Global Compact Türkiye
As GEN, we have become a member of Global Compact Türkiye, the world’s largest sustainability platform.
2023
GEN Azerbaijan Manufacturing Facility
In Baku, The groundbreaking ceremony for Azerbaijan's first pharmaceutical manufacturing facility was held on December 6, 2023. This facility will be established by Gen Pharma Caucasus Manufacturing Operations MMC, in which our company holds a 66% share.
